Proposed Amended Rule # 5.317
Statement of Authority, Basis And Purpose

The Statutory Authority for the adoption of this amended Rule # 5.317 is Section 12-60-101, Section 12-60-201, Section 12-60-202, Section 12-60-204, Section 12-60-501, Section 12-60-503, Section 12-60-507, Section 12-60-507.5, Section 12-60-508, Section 12-60-801, Section 12-60-802, and Section 12-60-803, C.R.S.

The Basis and Purpose for permanent adoption of this amended rule in the Colorado Racing Commission Rules is to conform to current practice in the horse racing industry and also to facilitate documentation respective to Colorado’s limited horse race meet.  

CURRENT RULE:

5.317 – Furosemide may be administered intravenously to a horse, which is entered to compete in a race. Except under the instructions of the Division veterinarian or the racing veterinarian for the purpose of removing a horse from the veterinarian’s list or to facilitate the collection of a post-race urine sample, Furosemide shall be permitted only after the Division veterinarian has placed the horse on the Furosemide list.  In order for a horse to be placed on the Furosemide list, the following process must be followed.

1: After the horse’s licensed trainer and licensed veterinarian determine that it would be in the horse’s best interests to race with Furosemide, they shall notify the Division veterinarian or his/her designee, using the prescribed form, that they wish the horse to be put on the Furosemide list.

2: The form must be received by the Division veterinarian or his/her designee by the proper time deadlines so as to ensure public notification.

3: A horse placed on the official Furosemide list must remain on that list unless the licensed trainer and licensed veterinarian submit a written request to remove the horse from the list. The request must be made to the Division veterinarian or his/her designee, on the proper form, no later than the time of entry.

4:  Furosemide shall be administered only on Association grounds.

5:  Upon the request of the Division representative, the veterinarian administering the authorized bleeder medication shall surrender the syringe used to administer such medication, which may then be submitted for testing.

PROPOSED AMENDED RULE:

5.317 - Furosemide may be administered intravenously to a horse, which is entered to compete in a race. Except under the instructions of the Division veterinarian or the racing veterinarian for the purpose of removing a horse from the veterinarian's list or to facilitate the collection of a post-race urine sample, Furosemide shall be permitted only after the Division veterinarian has placed the horse on the Furosemide list.  In order for a horse to be placed on the Furosemide list, the following process must be followed.
 
1: 

1:  IF THE HORSE HAS PARTICIPATED ON FUROSEMIDE IN ITS PREVIOUS START AND IS NOT A CERTIFIED BLEEDER, SUCH HORSE WILL BE AUTOMATICALLY ADDED BY THE DIVISION VETERINARIAN TO THE FUROSEMIDE LIST FOR THE CURRENT RACE MEET.
 
2:

2: After the horse's licensed trainer and licensed veterinarian determine that it would be in the horse's best interests to race with Furosemide FOR THE FIRST TIME OR AFTER A LAYOFF FROM THE USE OF FUROSEMIDE, they shall notify the Division veterinarian or his/her designee, using the prescribed form, that they wish the horse to be put on the Furosemide list.  A horse placed on the official furosemide list must remain on that list unless the licensed trainer and licensed veterinarian submit a written request to remove the horse from the list. the request must be made to the Division veterinarian or his/her designee, on the proper form, no later than the time of entry.
 
3:

4: 

3:  Furosemide shall be administered only on Association grounds.
 
	5:

4:  Upon the request of the Division representative, the veterinarian administering the authorized bleeder medication shall surrender the syringe used to administer such medication, which may then be submitted for testing.